These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6195134)

  • 1. A current view of the human Ia system based on serological and immunochemical analysis.
    Sorrentino R; Tanigaki N; Tosi R; Corte G
    Hum Immunol; 1983 Sep; 8(1):45-51. PubMed ID: 6195134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of immunologically functional subsets of human Ia-like antigens on a monoclonal antibody (Q5/13) immunoadsorbent.
    Quaranta V; Walker LE; Pellegrino MA; Ferrone S
    J Immunol; 1980 Oct; 125(4):1421-5. PubMed ID: 6157732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens.
    Quaranta V; Pellegrino MA; Ferrone S
    J Immunol; 1981 Feb; 126(2):548-52. PubMed ID: 6161181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines.
    Shaw S; Ziegler A; DeMars R
    Hum Immunol; 1985 Apr; 12(4):191-211. PubMed ID: 3921497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological dissection of human Ia molecules.
    Tosi R; Tanigaki N; Centis D; Ferrara GB; Pressman D
    J Exp Med; 1978 Dec; 148(6):1592-611. PubMed ID: 82605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR products are a subset of human Ia antigens.
    Makgoba MW; Fuggle SV; McMichael AJ; Morris PJ
    Nature; 1983 Feb; 301(5900):531-2. PubMed ID: 6185854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subsets of human Ia-like molecules defined by monoclonal antibodies.
    Carrel S; Tosi R; Gross N; Tanigaki N; Carmagnola AL; Accolla RS
    Mol Immunol; 1981 May; 18(5):403-11. PubMed ID: 6171715
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal antibody identifies a new Ia-like (p29,34) polymorphic system linked to the HLA-D/DR region.
    Nadler LM; Stashenko P; Hardy R; Tomaselli KJ; Yunis EJ; Schlossman SF; Pesando JM
    Nature; 1981 Apr; 290(5807):591-3. PubMed ID: 6163992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological discrimination of DR4 haplotypes by radioimmunoassay.
    Tanigaki N; Tosi R; Ferrara GB
    Immunogenetics; 1986; 23(1):38-46. PubMed ID: 2417945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR epitope region definition by use of monoclonal antibody probes.
    Grumet FC; Charron DJ; Fendly BM; Levy R; Ness DB
    J Immunol; 1980 Dec; 125(6):2785-9. PubMed ID: 6159421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.
    Rebai N; Malissen B; Pierres M; Accolla RS; Corte G; Mawas C
    Eur J Immunol; 1983 Feb; 13(2):106-11. PubMed ID: 6187579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assignment of determinants recognized by human alloantisera to HLA-D-subregion molecules by a lysostrip technique.
    Nuñez G; Stastny P
    Tissue Antigens; 1986 Apr; 27(4):185-95. PubMed ID: 2425451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). II. Blocking of anti-class I CTL clones by anti-DR MoAb.
    Anichini A; Ress S; Strassmann G; Bach FH
    Hum Immunol; 1985 Jun; 13(2):139-43. PubMed ID: 2409062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sharing of Ia antigens between species. IV. Interspecies cross-reactivity of monoclonal antibodies directed against polymorphic mouse Ia determinants.
    Lunney JK; Osborne BA; Sharrow SO; Devaux C; Pierres M; Sachs DH
    J Immunol; 1983 Jun; 130(6):2786-93. PubMed ID: 6406596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subset analysis of human class II molecules controlled by the DR2/Dw2 haplotype: two separate DR subsets carry the DR2 specificity.
    Tanigaki N; Tosi R; Ferrara GB
    Immunogenetics; 1986; 24(2):95-102. PubMed ID: 2427443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA serology--1983.
    Grumet FC
    Prog Clin Biol Res; 1984; 149():207-20. PubMed ID: 6204338
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoclonal antibodies recognizing canine and human Ia-like antigens.
    Alejandro R; Shienvold FL; Latif Z; Esquenazi V; Miller J; Mintz DH
    Transplantation; 1984 Nov; 38(5):542-4. PubMed ID: 6208659
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of MHC class II antigenic determinants in the function of human antigen binding T8+ cells, monocytes and helper and suppressor factors.
    Lehner T; Jones T
    Clin Exp Immunol; 1984 Jun; 56(3):683-93. PubMed ID: 6204796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of anti-DQ alloantisera correlated with DR5.
    Crepaldi T; Fasano ME; Frattasio C; Centis D; Curtoni ES; Richiardi P
    J Immunogenet; 1985 Dec; 12(6):301-8. PubMed ID: 2426368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants.
    MacLean GD; Seehafer J; Shaw AR; Kieran MW; Longenecker BM
    J Natl Cancer Inst; 1982 Aug; 69(2):357-64. PubMed ID: 6180206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.